| The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors KP Romano, A Ali, C Aydin, D Soumana, A Özen, LM Deveau, C Silver, ... PLoS pathogens 8 (7), e1002832, 2012 | 255 | 2012 |
| Activation mechanism of oncogenic deletion mutations in BRAF, EGFR, and HER2 SA Foster, DM Whalen, A Özen, MJ Wongchenko, JP Yin, I Yen, ... Cancer cell 29 (4), 477-493, 2016 | 218 | 2016 |
| Molecular basis for drug resistance in HIV-1 protease A Ali, RM Bandaranayake, Y Cai, NM King, M Kolli, S Mittal, JF Murzycki, ... Viruses 2 (11), 2509, 2010 | 183 | 2010 |
| Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance MNL Nalam, A Ali, MD Altman, GSKK Reddy, S Chellappan, V Kairys, ... Journal of virology 84 (10), 5368-5378, 2010 | 139 | 2010 |
| Extreme entropy–enthalpy compensation in a drug-resistant variant of HIV-1 protease NM King, M Prabu-Jeyabalan, RM Bandaranayake, MNL Nalam, ... ACS chemical biology 7 (9), 1536-1546, 2012 | 105 | 2012 |
| Discovery of BLU-945, a reversible, potent, and wild-type-sparing next-generation EGFR mutant inhibitor for treatment-resistant non-small-cell lung cancer MS Eno, JD Brubaker, JE Campbell, C De Savi, TJ Guzi, BD Williams, ... Journal of medicinal chemistry 65 (14), 9662-9677, 2022 | 97 | 2022 |
| Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope A Özen, T Haliloğlu, CA Schiffer Journal of molecular biology 410 (4), 726-744, 2011 | 94 | 2011 |
| Clusters of isoleucine, leucine, and valine side chains define cores of stability in high‐energy states of globular proteins: Sequence determinants of structure and stability SV Kathuria, YH Chan, RP Nobrega, A Özen, CR Matthews Protein Science 25 (3), 662-675, 2016 | 79 | 2016 |
| Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance A Ali, C Aydin, R Gildemeister, KP Romano, H Cao, A Özen, D Soumana, ... ACS chemical biology 8 (7), 1469-1478, 2013 | 75 | 2013 |
| Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease SK Lee, M Potempa, M Kolli, A Özen, CA Schiffer, R Swanstrom Journal of Biological Chemistry 287 (16), 13279-13290, 2012 | 63 | 2012 |
| Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease A Özen, KH Lin, N Kurt Yilmaz, CA Schiffer Proceedings of the National Academy of Sciences 111 (45), 15993-15998, 2014 | 55 | 2014 |
| Improving the resistance profile of hepatitis C NS3/4A inhibitors: Dynamic substrate envelope guided design A Özen, W Sherman, CA Schiffer Journal of chemical theory and computation 9 (12), 5693-5705, 2013 | 47 | 2013 |
| Machine learning integration for predicting the effect of single amino acid substitutions on protein stability A Özen, M Gönen, E Alpaydın, T Haliloğlu BMC Structural Biology 9, 1-17, 2009 | 39 | 2009 |
| HIV-1 protease and substrate coevolution validates the substrate envelope as the substrate recognition pattern A Özen, T Haliloğlu, CA Schiffer Journal of Chemical Theory and Computation 8 (2), 703-714, 2012 | 34 | 2012 |
| HIV-1 protease-substrate coevolution in nelfinavir resistance M Kolli, A Özen, N Kurt-Yilmaz, CA Schiffer Journal of virology 88 (13), 7145-7154, 2014 | 29 | 2014 |
| Molecular basis for differential patterns of drug resistance in influenza N1 and N2 neuraminidase KL Prachanronarong, A Özen, KM Thayer, LS Yilmaz, KB Zeldovich, ... Journal of chemical theory and computation 12 (12), 6098-6108, 2016 | 25 | 2016 |
| Selectively modulating conformational states of USP7 catalytic domain for activation A Özen, L Rouge, C Bashore, BR Hearn, NJ Skelton, EC Dueber Structure 26 (1), 72-84. e7, 2018 | 20 | 2018 |
| Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors A Özen, K Prachanronarong, AN Matthew, DI Soumana, CA Schiffer Critical reviews in biochemistry and molecular biology 54 (1), 11-26, 2019 | 18 | 2019 |
| Drug‐resistant HIV‐1 protease regains functional dynamics through cleavage site coevolution N Özer, A Özen, CA Schiffer, T Haliloğlu Evolutionary applications 8 (2), 185-198, 2015 | 12 | 2015 |
| The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS-and RAF-Driven Cancers MB Ryan, B Quade, N Schenk, Z Fang, M Zingg, SE Cohen, BM Swalm, ... Cancer Discovery, OF1-OF16, 2024 | 5 | 2024 |
Celia A SchifferProfessor and Chair of Biochemistry and Molecular Biotechnology, U Mass Chan Medical School在 umassmed.edu 的电子邮件经过验证
